Is There a Cure Ahead?
Moving forward, Garsky must try to maintain a balance at Johnson between the controls throughout the firm that are necessary to protect its reputation and the freedom for the business units that can allow it to keep growing. Quality problems have persisted, as the firm announced in early 2012 that it would recall about a half-million bottles of liquid inquid infants’ Tylenol because of a faulty dosing system. Additionally ,McNeil is. Still working with the FDA to bring the plant that was the source of many of the over-the-counter recalls up to federal standards.